283 related articles for article (PubMed ID: 30862519)
1. Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014.
Yan BY; Lv JJ; Liu JY; Feng Y; Wu WL; Xu AQ; Zhang L
Int J Infect Dis; 2019 May; 82():129-134. PubMed ID: 30862519
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of hepatitis A antibody among population covered by different hepatitis A immunization strategies in Shandong Province, 2015, China].
Kong Q; Yan BY; Lyu JJ; Feng Y; Liu JY; Song LZ; Xu Q; Zhang L; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):480-483. PubMed ID: 28592089
[No Abstract] [Full Text] [Related]
3. The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005-2018.
Guo Y; Zhang L; Feng D; Zhao S; Liu Q; Xu J; Lu M; Li J; Zhang Y; Guo W
Int J Infect Dis; 2020 Apr; 93():163-167. PubMed ID: 32045695
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
6. Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System.
Wang F; Sun X; Wang F; Zheng H; Jia Z; Zhang G; Bi S; Miao N; Zhang S; Cui F; Li L; Wang H; Liang X; Rodewald LE; Feng Z; Yin Z; Shen L
Hepatology; 2021 Apr; 73(4):1251-1260. PubMed ID: 32592242
[TBL] [Abstract][Full Text] [Related]
7. Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017.
Wang H; Gao P; Chen W; Bai S; Lv M; Ji W; Pang X; Wu J
Hum Vaccin Immunother; 2019; 15(2):420-425. PubMed ID: 30260275
[TBL] [Abstract][Full Text] [Related]
8. Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
Lee YL; Lin KY; Cheng CY; Li CW; Yang CJ; Tsai MS; Tang HJ; Lin TY; Wang NC; Lee YC; Lin SP; Huang YS; Sun HY; Zhang JY; Ko WC; Cheng SH; Lee YT; Liu CE; Hung CC;
PLoS One; 2017; 12(10):e0186338. PubMed ID: 29036227
[TBL] [Abstract][Full Text] [Related]
9. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
Sun X; Wang F; Zheng H; Miao N; Yuan Q; Cui F; Yin Z; Zhang G; Levine H
Vaccine; 2018 Feb; 36(10):1279-1284. PubMed ID: 29398275
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)].
Li JP; Gao ZX; Zhou J
Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):238-40. PubMed ID: 20726266
[TBL] [Abstract][Full Text] [Related]
11. Changing epidemiology of hepatitis A infection in Izmir, Turkey.
Kurugol Z; Aslan A; Turkoglu E; Koturoglu G
Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.
Zhang ZL; Zhu XJ; Shan AL; Gao ZG; Zhang Y; Ding YX; Liu H; Wu WS; Liu Y; He HY; Xie XH; Xia WD; Li C; Xu WT; Li ZY; Lin HL; Fu WM
Hum Vaccin Immunother; 2014; 10(4):1008-12. PubMed ID: 24503599
[TBL] [Abstract][Full Text] [Related]
13. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M
J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination.
Chironna M; Prato R; Sallustio A; Martinelli D; Tafuri S; Quarto M; Germinario C
BMC Infect Dis; 2012 Oct; 12():271. PubMed ID: 23098290
[TBL] [Abstract][Full Text] [Related]
15. Waning of anti-HAV immunity in Shijiazhuang prefecture, Hebei province, China: a comparison of seroprevalence between 1992 and 2011.
Chen Y; Zhang XJ; Zhao YL; Zhang YH; Wang SM; Hao ZY; Zhang ZY; Ma JC; Fang Y; Wang XY
Vaccine; 2014 Oct; 32(47):6227-32. PubMed ID: 25258099
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Hepatitis A Twelve Years After the Implementation of Toddlers' Vaccination: A Population-Based Study in Israel.
Bassal R; Weil M; Cohen D; Sofer D; Mendelson E; Shohat T
Pediatr Infect Dis J; 2017 Oct; 36(10):e248-e251. PubMed ID: 28498301
[TBL] [Abstract][Full Text] [Related]
17. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH
Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164
[TBL] [Abstract][Full Text] [Related]
18. Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China - A cross-sectional study.
Xiaojin S; Rodewald LE; Guomin Z; Hui Z; Ning M; Fuzhen W; Zundong Y
Vaccine; 2020 Dec; 38(52):8302-8309. PubMed ID: 33213930
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis A immunity in Yozgat, Turkey.
Kader Ç; Göçmen AY; Demir MI; Çolak NY; Gök SE; Arkan FI; Sara MY; Erbay A
Ann Saudi Med; 2019; 39(1):37-41. PubMed ID: 30712049
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.
Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
